XML 20 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - EUR (€)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities      
Net income (loss) € 699,890 € (1,703,668) € 1,512,057
Adjustments to reconcile net income (loss) to net cash generated by (used in) operating activities:      
Depreciation and amortization 1,920,000 2,105,000 1,879,000
Share based compensation 1,900,000 160,000 260,000
US Paycheck Protection Program Forgiveness (187,000)    
Change in allowances for doubtful accounts & slow-moving inventories 363,000 734,000 176,000
Change in long-term provisions (350,000) 455,000 (6,000)
Net capital loss on disposals of assets 142,000 291,000 79,000
Deferred tax expense (benefit) (563,000) 45,000 (106,000)
Operating cash flow 3,925,000 2,087,000 3,794,000
Increase/Decrease in operating assets and liabilities:      
Decrease (Increase) in trade accounts and notes and other receivables (103,000) 1,137,000 908,000
Decrease (Increase) in inventories 166,000 (554,000) (1,036,000)
Decrease (Increase) in other assets (210,000) 69,000 (60,000)
(Decrease) Increase in trade accounts and notes payable (38,000) (422,000) (249,000)
(Decrease) Increase in accrued expenses, other current liabilities 706,000 (339,000) 445,000
Net change in operating assets and liabilities 520,000 (110,000) 6,000
Net cash generated by (used in) operating activities 4,445,000 1,977,000 3,800,000
Cash flows from investing activities:      
Additions to capitalized assets produced by the Company (1,161,000) (1,339,000) (1,020,000)
Acquisitions of property and equipment (393,000) (531,000) (396,000)
Acquisitions of intangible assets (92,000) (103,000) (35,000)
Decrease (Increase) of other financial assets 13,000 (2,000) (14,000)
Increase in deposits and guarantees (6,000) (36,000) (67,000)
Net cash generated by (used in) investing activities (1,638,000) (2,011,000) (1,532,000)
Cash flow from financing activities:      
Proceeds from capital increase [1] 21,289,000    
Proceeds from stock-option exercise 442,000 60,000 310,000
Proceeds from long term borrowings, net of financing costs 1,058,000 4,848,000 688,000
Repayment of long term borrowings (1,401,000) (519,000) (1,087,000)
Repayment of obligations under financing leases (406,000) (321,000) (396,000)
Increase (decrease) in bank overdrafts and short-term borrowings (717,000) (867,000) (179,000)
Net cash generated by (used in) financing activities 20,266,000 3,201,000 (664,000)
Net effect of exchange rate changes on cash and cash equivalents (585,000) 642,000 (182,000)
Net increase (decrease) in cash and cash equivalents 22,488,000 3,810,000 1,422,000
Cash and cash equivalents at beginning of year 24,696,000 20,886,000 19,464,000
Cash and cash equivalents at end of year € 47,183,000 € 24,696,000 € 20,886,000
[1] The proceeds from capital increase of €21,289 thousands relate to the Company’s successful common stock offering in April 2021 – refer to note 17-1.